BIOE — Bio Essence Corp

—
OTC · Health Care · Pharmaceuticals · CIK 1723059 ·
Last close
$0.47
Market Cap
$25.29M
52W High
$0.52
52W Low
$0.05
ADV30
7,983
Next earnings
—
Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 794,711 470,261 279,290 270,077 4,002,945 675 1,660,388
Mar 2026 500,537 319,353 215,795 205,373 789,032 36,177 2,216,552
Dec 2025 1,479,454 1,143,421 1,029,627 1,029,087 422,474 0 2,495,367
Sep 2025 136,800 95,760 14,253 12,998 184,534 28,741 3,286,514

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,075,705
Investing CF
—
Financing CF
$-990,203
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-9,077,623
Inventory
—
Receivables
$595,832
ST Investments
—
EBIT TTM
$1,538,225
Pretax Income TTM
$1,537,785
Interest Exp TTM
$2,185
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,911,502
EBITDA
$1,642,741
Free Cash Flow
$25,637
Enterprise Value
$11,355,225
Total Cash
$675
Total Debt
$1,568,043
Shares Out
53,809,000
Trailing EPS
$0.03
Book Value
$-0.06
ROE
—
ROA
46.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,897,566 900,011 896,197 422,474 2,495,367 -2,072,893 1,569,753
Dec 2024 323,940 -459,438 -1,308,796 281,024 3,250,114 -2,969,090 623,865
Dec 2023 0 -345,590 -971,879 2,758,580 4,418,874 -1,660,294 -1,025,673
Dec 2022 621,590 -511,138 -809,679 1,547,725 4,786,140 -3,238,415 -703,241
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$2,911,502
NetIncome TTM
$1,517,535
OpCashFlow TTM
—
Assets (Latest)
$4,002,945
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
ABVC ABVC BIOPHARMA, INC. $25.36M $0.94 —
AARD Aardvark Therapeutics, Inc. $25.17M $1.15 —
CLCS Cell Source, Inc. $25.14M $0.37 —
BETRF BetterLife Pharma Inc. $25.64M $0.15 —
ACET Adicet Bio, Inc. $26.03M $2.78 —

News headlines (Yahoo Finance, 1h cache)

Bio Essence Unveils Practitioner-Controlled Knowledge Vault, Tackling AI's Trust Barrier in Healthcare
2026-10-29 12:00 · Yahoo
Bio Essence Corp Appoints Xiying (Thea) Zhang and Geoff Fellows as Independent Directors to Its Board
2026-10-26 12:00 · Yahoo
Bio Essence Corporation Expands MediFlow Platform with Development of Practitioner-Specific AI and RAG Technology
2026-10-15 12:00 · Yahoo
Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
2026-04-27 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.